Page last updated: 2024-11-07

paramethasone and Substance Withdrawal Syndrome

paramethasone has been researched along with Substance Withdrawal Syndrome in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brinkmann, W1
Klein, B1
Möller, E1

Trials

1 trial available for paramethasone and Substance Withdrawal Syndrome

ArticleYear
[Is the rebound effect in liver diseases following glucocorticoid therapy avoidable by using alpha-lipoic acid?].
    Therapie der Gegenwart, 1971, Volume: 110, Issue:12

    Topics: Chronic Disease; Drug Interactions; Humans; Liver Diseases; Paramethasone; Substance Withdrawal Synd

1971